Evaluation of anxiolytic activity of compound <it>Valeriana jatamansi</it> Jones in mice
<p>Abstract</p> <p>Background</p> <p>Compound <it>Valeriana jatamansi</it> Jones is a formula for treating anxiety-related diseases in the clinic, which is composed of <it>Valeriana jatamansi</it> Rhizoma et Radix, <it>Ziziphi Spinosae</...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | BMC Complementary and Alternative Medicine |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1472-6882/12/223 |
id |
doaj-a21e8c2f24c7449d88f0c32bc2f3d6a1 |
---|---|
record_format |
Article |
spelling |
doaj-a21e8c2f24c7449d88f0c32bc2f3d6a12020-11-25T02:20:39ZengBMCBMC Complementary and Alternative Medicine1472-68822012-11-0112122310.1186/1472-6882-12-223Evaluation of anxiolytic activity of compound <it>Valeriana jatamansi</it> Jones in miceYou Jie-ShuPeng MinShi Jin-LiZheng Hu-ZhanLiu YongZhao Bao-ShengGuo Jian-You<p>Abstract</p> <p>Background</p> <p>Compound <it>Valeriana jatamansi</it> Jones is a formula for treating anxiety-related diseases in the clinic, which is composed of <it>Valeriana jatamansi</it> Rhizoma et Radix, <it>Ziziphi Spinosae</it> Semen, <it>Albiziae</it> Cortex and Junci Medulla. The purpose of this study was to explore the anxiolytic properties of this compound in mice.</p> <p>Methods</p> <p>Male ICR mice were treated with compound <it>Valerianae Jatamansi</it> Jones (1.2 g/kg, 2.4 g/kg, 4.8 g/kg), saline, diazepam (2 mg/kg) orally for 10 days and then exposed to elevated maze-plus (EPM) and light–dark box (LDB). The effects of the compound on spontaneous activity were evaluated by locomotor activity test. We further investigated the mechanism of action underlying the anxiolytic-like effect of compound by pre-treating animals with antagonists of benzodiazepine (flumazenil, 3mg/kg) prior to evaluation using EPM and LDB.</p> <p>Results</p> <p>Compound <it>Valerianae Jatamansi</it> Jones (2.4, 4.8 g/kg, p.o.) significantly increased entries (<it>P</it><0.05) into and time spent (<it>P</it><0.05) on the open arms of the EPM, and number of transitions (<it>P</it><0.05) and time spent (<it>P</it><0.05) in the light compartment of the LDB. However, the anxiolytic-like effects of compound were significantly reduced by pre-treatment with flumazenil (<it>P</it>>0.05). In addition, compound <it>Valerianae Jatamansi</it> Jones treatment didn’t affect the spontaneous activity in mice (<it>P</it>> 0.05).</p> <p>Conclusions</p> <p>The present study supports the hypothesis that compound <it>Valeriana jatamansi</it> Jones exert anxiolytic action but no sedative effects in mice and that this effect might be mediated by benzodiazepine receptors.</p> http://www.biomedcentral.com/1472-6882/12/223Compound <it>Valeriana jatamansi</it> JonesAnxiolyticElevated maze-plusLight���dark boxBenzodiazepine receptors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
You Jie-Shu Peng Min Shi Jin-Li Zheng Hu-Zhan Liu Yong Zhao Bao-Sheng Guo Jian-You |
spellingShingle |
You Jie-Shu Peng Min Shi Jin-Li Zheng Hu-Zhan Liu Yong Zhao Bao-Sheng Guo Jian-You Evaluation of anxiolytic activity of compound <it>Valeriana jatamansi</it> Jones in mice BMC Complementary and Alternative Medicine Compound <it>Valeriana jatamansi</it> Jones Anxiolytic Elevated maze-plus Light���dark box Benzodiazepine receptors |
author_facet |
You Jie-Shu Peng Min Shi Jin-Li Zheng Hu-Zhan Liu Yong Zhao Bao-Sheng Guo Jian-You |
author_sort |
You Jie-Shu |
title |
Evaluation of anxiolytic activity of compound <it>Valeriana jatamansi</it> Jones in mice |
title_short |
Evaluation of anxiolytic activity of compound <it>Valeriana jatamansi</it> Jones in mice |
title_full |
Evaluation of anxiolytic activity of compound <it>Valeriana jatamansi</it> Jones in mice |
title_fullStr |
Evaluation of anxiolytic activity of compound <it>Valeriana jatamansi</it> Jones in mice |
title_full_unstemmed |
Evaluation of anxiolytic activity of compound <it>Valeriana jatamansi</it> Jones in mice |
title_sort |
evaluation of anxiolytic activity of compound <it>valeriana jatamansi</it> jones in mice |
publisher |
BMC |
series |
BMC Complementary and Alternative Medicine |
issn |
1472-6882 |
publishDate |
2012-11-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Compound <it>Valeriana jatamansi</it> Jones is a formula for treating anxiety-related diseases in the clinic, which is composed of <it>Valeriana jatamansi</it> Rhizoma et Radix, <it>Ziziphi Spinosae</it> Semen, <it>Albiziae</it> Cortex and Junci Medulla. The purpose of this study was to explore the anxiolytic properties of this compound in mice.</p> <p>Methods</p> <p>Male ICR mice were treated with compound <it>Valerianae Jatamansi</it> Jones (1.2 g/kg, 2.4 g/kg, 4.8 g/kg), saline, diazepam (2 mg/kg) orally for 10 days and then exposed to elevated maze-plus (EPM) and light–dark box (LDB). The effects of the compound on spontaneous activity were evaluated by locomotor activity test. We further investigated the mechanism of action underlying the anxiolytic-like effect of compound by pre-treating animals with antagonists of benzodiazepine (flumazenil, 3mg/kg) prior to evaluation using EPM and LDB.</p> <p>Results</p> <p>Compound <it>Valerianae Jatamansi</it> Jones (2.4, 4.8 g/kg, p.o.) significantly increased entries (<it>P</it><0.05) into and time spent (<it>P</it><0.05) on the open arms of the EPM, and number of transitions (<it>P</it><0.05) and time spent (<it>P</it><0.05) in the light compartment of the LDB. However, the anxiolytic-like effects of compound were significantly reduced by pre-treatment with flumazenil (<it>P</it>>0.05). In addition, compound <it>Valerianae Jatamansi</it> Jones treatment didn’t affect the spontaneous activity in mice (<it>P</it>> 0.05).</p> <p>Conclusions</p> <p>The present study supports the hypothesis that compound <it>Valeriana jatamansi</it> Jones exert anxiolytic action but no sedative effects in mice and that this effect might be mediated by benzodiazepine receptors.</p> |
topic |
Compound <it>Valeriana jatamansi</it> Jones Anxiolytic Elevated maze-plus Light���dark box Benzodiazepine receptors |
url |
http://www.biomedcentral.com/1472-6882/12/223 |
work_keys_str_mv |
AT youjieshu evaluationofanxiolyticactivityofcompounditvalerianajatamansiitjonesinmice AT pengmin evaluationofanxiolyticactivityofcompounditvalerianajatamansiitjonesinmice AT shijinli evaluationofanxiolyticactivityofcompounditvalerianajatamansiitjonesinmice AT zhenghuzhan evaluationofanxiolyticactivityofcompounditvalerianajatamansiitjonesinmice AT liuyong evaluationofanxiolyticactivityofcompounditvalerianajatamansiitjonesinmice AT zhaobaosheng evaluationofanxiolyticactivityofcompounditvalerianajatamansiitjonesinmice AT guojianyou evaluationofanxiolyticactivityofcompounditvalerianajatamansiitjonesinmice |
_version_ |
1724870914392195072 |